Burris, H.A. (2004) Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB-2 Inhibitor Lapatinib. The Oncologist, 9, 10-15. https://doi.org/10.1634/theoncologist.9-suppl_3-10
has been cited by the following article:
Related Articles: